Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

The Odisha government is set to host the Odisha Pharma Summit 2025 on December 16. This event aims to unite stakeholders from the pharmaceutical and medical devices industries to explore new opportunities. Chief Minister Mohan Charan Majhi will inaugurate the programme. An official mentioned that the state will introduce the Odisha Pharmaceutical and Medical Devices Policy 2025 during this event.

The new policy is designed to attract investments, enhance business ease, and generate large-scale employment in the life sciences sector. Additionally, the government plans to announce the development of a Pharmaceutical Park and a Medical Devices Park. These initiatives aim to bolster the state’s healthcare manufacturing infrastructure and promote industry growth.

Focus on Industry Growth
Industries Minister Sampad Chandra Swain stated, “Odisha welcomes all pharma, medical devices & related sector industries, investors, and thought leaders to join us at this summit. We are committed to building a strong, future-ready ecosystem that supports growth, innovation, and global competitiveness.” The summit will also feature the signing of MoUs between the government and leading companies.

This collaboration marks a significant step towards enhancing the state’s pharmaceutical and medical devices ecosystem. The government encourages healthcare and industry enthusiasts to participate in this initiative, which aims to shape the future of the sector in Odisha.

The event’s agenda includes discussions on investment opportunities and strategies for improving business operations in the life sciences field. By bringing together industry leaders and investors, Odisha aims to position itself as a hub for pharmaceutical and medical device manufacturing.

Related Posts

HP accounts for 47 inferior drugs in March alert

Kullu: In an alert issued for the month of March, the Central Drugs Standard Control Organisation (CDSCO) has declared a total of 141 drugs to be of substandard quality. Out…

Civil society group SAM calls for greater transparency involving clinical trials

The group had approached the Supreme Court, raising concerns on clinical trials in a Public Interest Litigation in 2012 Civil society group Swasthya Adhikar Manch (SAM) has called for greater…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

Rajasthan Bans 7 Sub-Standard Medicines

Rajasthan Bans 7 Sub-Standard Medicines